These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10348372)

  • 1. The interaction of immunomodulatory muramyl dipeptide with peripheral 5-HT receptors: overview of the current state.
    Sevcík J; Masek K
    Int J Immunopharmacol; 1999 Mar; 21(3):227-32. PubMed ID: 10348372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDP and 5-HT receptors. Does MDP interact with 5-HT(7) receptors?
    Sevcík J; Rûzicka V; Slánský J; Masek K
    Int J Immunopharmacol; 2000 Aug; 22(8):587-95. PubMed ID: 10988353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
    Polanski M; Karnovsky ML
    J Neuroimmunol; 1992 Mar; 37(1-2):149-60. PubMed ID: 1532180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immunomodulator muramyl dipeptide on serotoninergic responses of isolated neuromuscular preparations.
    Slánský J; Kadlec O; Masek K; Gulda O
    Pharmacology; 1994 Jan; 48(1):11-20. PubMed ID: 8309983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of monoaminergic neurotransmitter systems in MDP-induced adjuvant effect.
    Strnadová V; Masek K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):391-5. PubMed ID: 1679149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplicity of biological effects of muramyl dipeptide.
    Masek K
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):97-9. PubMed ID: 3713377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
    Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of brain structures in the adjuvant effect of muramyl dipeptide.
    Masek K; Kadlecová O; Petrovický P
    Brain Res Bull; 1985 Nov; 15(5):443-6. PubMed ID: 2998564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological study of local skin injected with adjuvant-active and -inactive muramyl dipeptide (MDP) (histological change in MDP injected skin.
    Okuyama H; Kobayashi S; Azuma I
    Asian Pac J Allergy Immunol; 1983 Dec; 1(2):89-96. PubMed ID: 6681013
    [No Abstract]   [Full Text] [Related]  

  • 10. Muramyl dipeptide mimicry in the regulation of murine macrophage activation by serotonin.
    Polanski M; Vermeulen MW; Wu J; Karnovsky ML
    Int J Immunopharmacol; 1995 Mar; 17(3):225-32. PubMed ID: 7558518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and pharmacological evidence for the existence of brain regulatory circuits in the immune response.
    Masek K; Petrovický P
    Int J Immunopharmacol; 1997; 19(9-10):507-10. PubMed ID: 9637346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somnogenic activity of muramyl peptide-derived immune adjuvants.
    Johannsen L; Obál F; Kapás L; Kovalzon V; Krueger JM
    Int J Immunopharmacol; 1994 Feb; 16(2):109-16. PubMed ID: 8181899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence on the interaction of muramyl dipeptide with the serotonergic system.
    Slánský J; Kadlec O; Sevcík J; Masek K
    Int J Immunopharmacol; 1996 Jan; 18(1):23-9. PubMed ID: 8732429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
    Sulcová A; Krsiak M; Masek K; Gulda O
    Act Nerv Super (Praha); 1989 Jun; 31(2):127-9. PubMed ID: 2800947
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
    Zídek Z
    Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunostimulating activity of muramyl dipeptide and its derivatives].
    Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
    Akasaki M; Takashi T; Kita Y; Tsukada W
    Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.